Clinical Trials Insight: 700013616

Trial Profile

Clinical Trials Insight: 700013616

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 15 Apr 2008

At a glance

  • Drugs LX 6171 (Primary)
  • Indications Cognition disorders; Dementia; Schizophrenia
  • Focus Adverse reactions
  • Sponsors Lexicon Pharmaceuticals
  • Most Recent Events

    • 15 Apr 2008 Preliminary data reported at the American Academy of Neurology 2008
    • 08 Sep 2006 Status change
    • 03 Jul 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top